OpenAlex
PricingAboutJobs
Log inGet started
Work

The toxic and hematologic effects of interleukin-1 alpha administered in a phase I trial to patients with advanced malignancies.

HTML

Year: 1992
Type: article
Study design: Clinical Trial
Source: Journal of Clinical Oncology
DOI: 10.1200/jco.1992.10.7.1141
Authors: J W Smith, W J Urba, B D Curti, L J Elwood, R G Steis, J E Janik, W H Sharfman, L L Miller, R G Fenton, K C Conlon
Institution: National Institutes of Health
Language: English

Topic: Immunotoxicology and immune responses
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Keywords: interleukin-1 alpha, advanced solid tumors, maximum tolerated dose, indomethacin, hypotension, dose-limiting toxicity, hematological effects, neutrophilia, platelet count, bone marrow cellularity, interleukin-6, cytokine therapy
SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute
Awards: OPERATIONS AND TECHNICAL SUPPORT, G2246755306
OpenAlex ID: W2227468111
FWCI: 5.878
Cites: 30
Cited by: 169
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Supporters
Legal
Privacy
Accessibility
Terms